Loss-of-function Mutations in SLC30A8 Protect Against Type 2 Diabetes

Loss-of-function mutations protective against human disease provide in vivo validation of therapeutic targets, but none have yet been described for type 2 diabetes (T2D). Through sequencing or genotyping of ~150,000 individuals across 5 ancestry groups, we identified 12 rare protein-truncating variants in SLC30A8, which encodes an islet zinc transporter (ZnT8) and harbors a common variant (p.Trp325Arg) associated with T2D risk and glucose and proinsulin levels. Collectively, carriers of protein-truncating variants had 65% reduced T2D risk (P = 1.7 × 10(-6)), and non-diabetic Icelandic carriers of a frameshift variant (p.Lys34Serfs*50) demonstrated reduced glucose levels (-0.17 s.d., P = 4.6 × 10(-4)). The two most common protein-truncating variants (p.Arg138* and p.Lys34Serfs*50) individually associate with T2D protection and encode unstable ZnT8 proteins. Previous functional study of SLC30A8 suggested that reduced zinc transport increases T2D risk, and phenotypic heterogeneity was observed in mouse Slc30a8 knockouts. In contrast, loss-of-function mutations in humans provide strong evidence that SLC30A8 haploinsufficiency protects against T2D, suggesting ZnT8 inhibition as a therapeutic strategy in T2D prevention.

Citing Articles

Pathways to chronic disease detection and prediction: Mapping the potential of machine learning to the pathophysiological processes while navigating ethical challenges.

Afrifa-Yamoah E, Adua E, Peprah-Yamoah E, Anto E, Opoku-Yamoah V, Acheampong E Chronic Dis Transl Med. 2025; 11(1):1-21.

PMID: 40051825 PMC: 11880127. DOI: 10.1002/cdt3.137.

High Serum Zinc Concentration Accelerates Progression of Isolated Impaired Glucose Tolerance to Type 2 Diabetes: A Cohort Study.

Bahadoran Z, Ghafouri-Taleghani F, Azizi F, Ghasemi A Biol Trace Elem Res. 2025; .

PMID: 39939554 DOI: 10.1007/s12011-025-04545-w.

The role of protective genetic variants in modulating epigenetic aging.

Bejaoui Y, Srour L, Qannan A, Oshima J, Saad C, Horvath S Geroscience. 2025; .

PMID: 39928272 DOI: 10.1007/s11357-025-01548-2.

Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings.

Chim S, Howell K, Dronzek J, Wu W, Van Hout C, Ferreira M Elife. 2024; 12.

PMID: 39671241 PMC: 11648992. DOI: 10.7554/eLife.90419.

A double knockout for zinc transporter 8 and somatostatin in mice reveals their distinct roles in regulation of insulin secretion and obesity.

Yang Z, Kirschke C, Cai Y, Huang L Genes Nutr. 2024; 19(1):24.

PMID: 39567934 PMC: 11580226. DOI: 10.1186/s12263-024-00759-0.

References

van de Bunt M, Gloyn A . From genetic association to molecular mechanism. Curr Diab Rep. 2010; 10(6):452-66. DOI: 10.1007/s11892-010-0150-2. View

Wijesekara N, Dai F, Hardy A, Giglou P, Bhattacharjee A, Koshkin V . Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia. 2010; 53(8):1656-68. PMC: 6101216. DOI: 10.1007/s00125-010-1733-9. View

Cohen J, Pertsemlidis A, Kotowski I, Graham R, Garcia C, Hobbs H . Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet. 2005; 37(2):161-5. DOI: 10.1038/ng1509. View

Morris A, Voight B, Teslovich T, Ferreira T, V Segre A, Steinthorsdottir V . Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44(9):981-90. PMC: 3442244. DOI: 10.1038/ng.2383. View

Lemaire K, Ravier M, Schraenen A, Creemers J, Van de Plas R, Granvik M . Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc Natl Acad Sci U S A. 2009; 106(35):14872-7. PMC: 2736467. DOI: 10.1073/pnas.0906587106. View

Bloom J, Pagano M . Experimental tests to definitively determine ubiquitylation of a substrate. Methods Enzymol. 2005; 399:249-66. DOI: 10.1016/S0076-6879(05)99017-4. View

Plenge R, Scolnick E, Altshuler D . Validating therapeutic targets through human genetics. Nat Rev Drug Discov. 2013; 12(8):581-94. DOI: 10.1038/nrd4051. View

Strawbridge R, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, Rybin D . Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes. 2011; 60(10):2624-34. PMC: 3178302. DOI: 10.2337/db11-0415. View

Chimienti F, Devergnas S, Favier A, Seve M . Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes. 2004; 53(9):2330-7. DOI: 10.2337/diabetes.53.9.2330. View

10.

Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D . A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445(7130):881-5. DOI: 10.1038/nature05616. View

11.

Hardy A, Wijesekara N, Genkin I, Prentice K, Bhattacharjee A, Kong D . Effects of high-fat diet feeding on Znt8-null mice: differences between β-cell and global knockout of Znt8. Am J Physiol Endocrinol Metab. 2012; 302(9):E1084-96. PMC: 3774340. DOI: 10.1152/ajpendo.00448.2011. View

12.

Nejentsev S, Walker N, Riches D, Egholm M, Todd J . Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science. 2009; 324(5925):387-9. PMC: 2707798. DOI: 10.1126/science.1167728. View

13.

da Silva Xavier G, Bellomo E, McGinty J, French P, Rutter G . Animal models of GWAS-identified type 2 diabetes genes. J Diabetes Res. 2013; 2013:906590. PMC: 3654344. DOI: 10.1155/2013/906590. View

14.

Waters P . Degradation of mutant proteins, underlying "loss of function" phenotypes, plays a major role in genetic disease. Curr Issues Mol Biol. 2001; 3(3):57-65. View

15.

Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson A . New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42(2):105-16. PMC: 3018764. DOI: 10.1038/ng.520. View

16.

Nassar M, Stirling L, Forlani G, Baker M, Matthews E, Dickenson A . Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A. 2004; 101(34):12706-11. PMC: 515119. DOI: 10.1073/pnas.0404915101. View

17.

Nicolson T, Bellomo E, Wijesekara N, Loder M, Baldwin J, Gyulkhandanyan A . Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes. 2009; 58(9):2070-83. PMC: 2731533. DOI: 10.2337/db09-0551. View

18.

Pound L, Sarkar S, Benninger R, Wang Y, Suwanichkul A, Shadoan M . Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochem J. 2009; 421(3):371-6. PMC: 2929527. DOI: 10.1042/BJ20090530. View

19.

Pound L, Sarkar S, Ustione A, Dadi P, Shadoan M, Lee C . The physiological effects of deleting the mouse SLC30A8 gene encoding zinc transporter-8 are influenced by gender and genetic background. PLoS One. 2012; 7(7):e40972. PMC: 3400647. DOI: 10.1371/journal.pone.0040972. View

20.

Mathieson I, McVean G . Differential confounding of rare and common variants in spatially structured populations. Nat Genet. 2012; 44(3):243-6. PMC: 3303124. DOI: 10.1038/ng.1074. View